Navigation Links
PipelineRx Announces Expansion into Ten New States with Telepharmacy Services
Date:9/25/2013

SAN FRANCISCO, Sept. 25, 2013 /PRNewswire/ -- PipelineRx, a leading medication management services and technology company focused on clinical telepharmacy, announces expansion into ten new states.  Centered around its proprietary private cloud telepharmacy technology platform, PipelineRx states that in addition to adding over 25 new customers in the first half of 2013, the Company has begun providing service to acute and specialty hospitals in Alaska, Florida, Georgia, New Jersey, Oregon, South Carolina, Utah, Vermont, West Virginia, and Wyoming.  PipelineRx continues to be one of the fastest growing businesses in the remote medication order entry (RMOE) segment and shows no signs of slowing.

(Logo:  http://photos.prnewswire.com/prnh/20121130/SF21549LOGO)

PipelineRx's President, Brian J. Roberts, notes that the national hospital market is taking notice of the Company's clear value proposition.  "PipelineRx provides an unparalleled level of clinical service and customer service to our clients.  We truly replicate and extend our customer pharmacies approach at a significantly lower and more predictable cost level.  We develop dedicated remote pharmacist teams that foster very close relationships with the nurses and doctors we serve."  This intimate approach to clinical services is clearly setting PipelineRx apart and providing a safer environment for patients and more efficient environment for hospital staff that are being serviced by PipelineRx pharmacists.

The recently announced PipelineRx Software as a Service (SaaS) technology solution is also fueling the
'/>"/>

SOURCE PipelineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PipelineRX Announces Two Contracts with Recently Launched Telepharmacy SaaS Solution
2. PipelineRx Announces Telepharmacy Contract with GNYHA Services
3. PipelineRx Completes Acquisition of Healthcare Connectivity Solutions Company Evolute Consolidated Holdings
4. Genarts 18th Annual Film Festival Announces Collaboration With The Partnership At Drugfree.org For #endmedicineabuse Project
5. Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
6. Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention
7. Misonix, Inc. Announces Fourth Quarter and Fiscal Year 2013 Financial Results
8. Edison Pharmaceuticals Announces Initiation of NIH-Sponsored EPI-743 Clinical Trial with NIH Undiagnosed Diseases Program Patients
9. Aethlon Medical Announces the Appointment of Dr. Cicek Gercel-Taylor as Clinical Research Director of Exosome Sciences, Inc.
10. K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers
11. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... TIJUANA, Mexico , Dec. 24, 2014 /PRNewswire/ ... treatment of its first patient in its study ... to the American Stroke Association, ischemic strokes account ... continues to enroll qualified patients in the study, ... Intravenous Administration of Allogeneic Mesenchymal Stem Cells and ...
(Date:12/24/2014)... -- Commonwealth Cornerstone Group (CCG) today announced the completion of an ... help fund the expansion and consolidation of healthcare services provided ... . PHN is the largest federally qualified ... is the largest employer in Sharon,s ... Currently, PHN Sharon offers scattered services out of ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, iFitDress.com, the ... for women, has announced its new selection of black ... are on sale now; they are available at discounted prices, ... says, “The promotion will last for three weeks only. You ... market. Those who are interested in our new items can ...
(Date:12/25/2014)... 25, 2014 BambooFlooringChina.com sells many bamboo ... bamboo flooring. Today, the company announces big discounts ... styles and colors. , BambooFlooringChina.com is the world’s leader ... promotion is valid until Jan. 20, 2015. , The ... woven with a natural thread. All the bamboo strips ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... chronic illnesses can receive effective, less expensive care from a ... to a team of dedicated health care professionals, a new ... ill and need either hospitalization or a trip to the ... home clinic at the University of Texas in Houston versus ...
(Date:12/25/2014)... By Dennis Thompson ... -- Researchers could be closing in on a "fountain of ... improve the health of older adults, a new study suggests. ... when given a drug that targets a genetic signaling pathway ... maker Novartis report. The experimental medication, a ...
(Date:12/25/2014)... Plugin creators from Pixel Film Studios ... customizable business presentation tool made specifically for Final ... business tool, users can now display their stats and ... Film Studios. “ProFire 5k gives users a multiple options ... to a presentation” , Pixel Film Studios takes the ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... cancers that respond best to tyrosine kinase inhibitors (TKIs), ... according to research presented at the 14th World Conference ... Association for the Study of Lung Cancer (IASLC). ... for non-small cell lung cancer therapy, selecting the best ...
... common type of liver cancer, is a leading cause ... options available, they are largely unsuccessful because the disease ... HCC, combined with studies using mice and other animal ... how to diagnose and treat this deadly form of ...
... therapy helps ease chronic low back pain and improve function, ... of Internal Medicine will publish in its July 5 ... massage, the trial found that both types of massage worked ... helps people with back pain to function even after six ...
... are two to three times more likely to develop a life-threatening ... study published on bmj.com today. The new ... your risk of developing a pulmonary embolism a common cause ... says that, although the risk is small equivalent to seven ...
... Recent studies have revealed potato chips and french fries to ... good reason. Have you ever wondered why you can,t eat ... the carbohydrates at fault. UC Irvine researchers Daniele Piomelli, ... make them nearly irresistible and trigger a surprising biological mechanism ...
... smoking is associated with a 72% increased risk of ... CMAJ ( Canadian Medical Association Journal ) (pre-embargo link ... cause of serious illness and death in smokers and ... Varenicline is one of the most commonly used drugs ...
Cached Medicine News:Health News:PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumors 2Health News:Research in fish provides new clues about deadly form of liver cancer 2Health News:Massage eases low back pain in randomized controlled trial 2Health News:Massage eases low back pain in randomized controlled trial 3Health News:Sitting for long periods doubles risk of blood clots in the lungs 2Health News:Body's natural marijuana-like chemicals make fatty foods hard to resist 2Health News:Varenicline for smoking cessation linked to increased risk of serious harmful cardiac events 2
Bard Coude-Tip Latex Urethral Catheter, Two Eyes (Tiemann Model)...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI....
Used for injection into urethral strictures, bladder neck contracture, and the bladder wall. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: